Lupus

Article	Citations
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends	78
Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression	74
Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups	58
10 Years of belimumab experience: What have we learnt?	50
Adult systemic lupus erythematosus in Egypt: The nation-wide spectrum of 3661 patients and world-wide standpoint	45
Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort	37
Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus	34
Inflammatory myositis in systemic lupus erythematosus	28
Seventy years after Hench’s Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus	27
16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome	26
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry	26
Predictive value of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-neutrophil ratio, and neutrophil-to-monocyte ratio in lupus nephritis	25
Syk inhibitor attenuates inflammation in lupus mice from FcgRIIb deficiency but not in pristane induction: the influence of lupus pathogenesis on the therapeutic effect	25
16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome	25
Systemic lupus erythematosus: The search for the ideal biomarker	24
Systemic lupus erythematosus–associated diffuse alveolar hemorrhage: a single-center, matched case–control study in China	22
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK	22
Immune thrombocytopenia and COVID-19: Case report and review of literature	22
Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort	21
Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: Observations from an Indian inception cohort	21
SIGLEC1 (CD169) is a sensitive biomarker for the deterioration of the clinical course in childhood systemic lupus erythematosus	20
Lupus, vaccinations and COVID-19: What we know now	20
Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus	20
Mortality in patients with systemic lupus erythematosus and neuropsychiatric involvement: A retrospective analysis from a tertiary referral center in the Netherlands	19
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality	19

COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)	19
Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis	18
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study	18
Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis	17
Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome	17
Cell-free DNA profiling in patients with lupus nephritis	17
Hepatic manifestations in systemic lupus erythematosus	17
Erosive arthritis in systemic lupus erythematosus: not only Rhupus	17
Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity	17
Understanding the dynamics of hydroxychloroquine blood levels in lupus nephritis	17
The importance of pregnancy planning in lupus pregnancies	16
Rituximab – The first twenty years	16
Medication adherence is influenced by resilience in patients with systemic lupus erythematosus	16
A comparison of the performance of the 2019 European League Against Rheumatism/American College of Rheumatology criteria and the 2012 Systemic Lupus International Collaborating Clinics criteria with t	16
Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center	15
Physician–patient interaction and medication adherence in lupus nephritis	15
In-hospital mortality and its predictors in a cohort of SLE from Northern India	14
Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis	14
Three functional variants in the NLRP3 gene are associated with susceptibility and clinical characteristics of systemic lupus erythematosus	14
Interleukin 23 is elevated in the serum of patients with SLE	14
Obesity increases the incidence of new-onset lupus nephritis and organ damage during follow-up in patients with systemic lupus erythematosus	14
CD4+CD28nullT cells are expanded in moderately active systemic lupus erythematosus and secrete pro-inflammatory interferon gamma, depending on the Disease Activity Index	14
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study	14
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study	14
Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis	14
Albumin-to-globulin ratio (AGR) as a potential marker of predicting lupus nephritis in Chinese patients with systemic lupus erythematosus	13
Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina	13
COVID-19 in systemic lupus erythematosus: A pooled analysis and systematic review of case reports and series	13
Associations of site-specific CD4+-T-cell hypomethylation within CD40-ligand promotor and enhancer regions with disease activity of women with systemic lupus erythematosus	13
The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients	13
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom	13
Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome	13
A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus di	13
Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature	13
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome	13
Patient experiences and strategies for coping with SLE: A qualitative study	13
Low expression of estrogen receptor β in renal tubular epithelial cells may cause hyperuricemia in premenopausal patients with systemic lupus erythematosus	13
Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study	13
Systemic lupus erythematosus in the intensive care unit: a systematic review	13
Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study	13
Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel	13
Insulin resistance and serum levels of adipokines in patients with systemic lupus erythematosus: a systematic review and meta-analysis	13
Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature	12
Prevalence, involved domains, and predictor of cognitive dysfunction in systemic lupus erythematosus	12
Cognitive impairment in systemic lupus erythematosus is negatively related to social role participation and quality of life: A systematic review	12
Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective	12
Clinical management of Lupus patients during the COVID-19 pandemic	12
Systemic lupus erythematosus patients have a distinct structural and functional skin microbiota compared with controls	12
The multi-targets mechanism of hydroxychloroquine in the treatment of systemic lupus erythematosus based on network pharmacology	12
Clinical features, disease activity and outcomes of Malaysian children with paediatric systemic lupus erythematosus: A cohort from a tertiary centre	12

Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis	12
Damage index for antiphospholipid syndrome during long term follow-up: Correlation between organ damage accrual and quality of life	12
COVID-19 in patients with systemic lupus erythematosus: A systematic review	12
Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study	12
Clinical characteristics and long-term outcomes of Libman–Sacks endocarditis in patients with systemic lupus erythematosus	11
A home-based exercise program during COVID-19 pandemic: Perceptions and acceptability of juvenile systemic lupus erythematosus and juvenile idiopathic arthritis adolescents.	11
Bioinformatic analysis of key biomarkers and immune filtration of skin biopsy in discoid lupus erythematosus	11
Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders	11
Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials	11
Lupus nephritis in a transgender woman on cross-sex hormone therapy: a case for the role of oestrogen in systemic lupus erythematosus	11
EBV load is associated with cfDNA fragmentation and renal damage in SLE patients	11
Physiopathology of pain in systemic erythematosus lupus	11
Rituximab use as induction therapy for lupus nephritis: a systematic review	11
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study	11
Evaluation of subclinical retinal microvascular changes in systemic lupus erythematosus patients using optical coherence tomography angiography and its relationship with disease activity	11
Outcome of clinical and subclinical myocardial injury in systemic lupus erythematosus – A prospective cohort study	10
Identifying co-morbid fibromyalgia in patients with systemic lupus erythematosus using the Multi-Dimensional Health Assessment Questionnaire	10
Myositis in systemic lupus erythematosus	10
The association of lupus nephritis with adverse pregnancy outcomes among women with lupus in North America	10
Hsa_circ_0012919 regulates expression of MDA5 by miR-125a-3p in CD4+ T cells of systemic lupus erythematous	10
A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis	10
Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine	10
Systemic lupus erythematosus and pregnancy: A retrospective single-center study of 215 pregnancies from Portugal	10
The new 2019-EULAR/ACR classification criteria specific domains at diagnosis can predict damage accrual in 670 childhood-onset systemic lupus erythematosus patients	10
Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls	10
Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies	10
Epstein–Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity	10
Safety and efficacy of telitacicept in refractory childhood-onset systemic lupus erythematosus: A self-controlled before–after trial	10
Diagnostic value of urinary monocyte chemoattractant protein-1 in evaluating the activity of lupus nephritis: a meta-analysis	10
Impact of the first wave of the COVID-19 pandemic on systemic lupus erythematosus patients: Results from a multi-center prospective cohort	9
Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine	9
New-onset lupus nephritis associated with COVID-19 infection	9
Low disease activity state in juvenile-onset systemic lupus erythematosus	9
Relationship between remission, disease activity and patient-reported outcome measures in patients with recent-onset systemic lupus erythematosus	9
Antiphospholipid syndrome–mediated acute cerebrovascular diseases and long-term outcomes	9
Severe pneumonia in Chinese patients with systemic lupus erythematosus	9
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome	9
Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis	9
Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus	9
What is the value of repeat kidney biopsies in patients with lupus nephritis?	9
Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study	9
Targets of Tripterygium glycosides in systemic lupus erythematosus treatment: A network-pharmacology study	9
Ofatumumab use in juvenile systemic lupus erythematosus: A single centre experience	9
Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study	9
Exploration of machine learning methods to predict systemic lupus erythematosus hospitalizations	9
Effect of indole-3-carbinol on transcriptional profiling of wound-healing genes in macrophages of systemic lupus erythematosus patients: an RNA sequencing assay	9
Soluble ST2 and CXCL-10 may serve as biomarkers of subclinical diastolic dysfunction in SLE and correlate with disease activity and damage	9
Maternal and fetal outcomes of lupus pregnancies: A collective effort by Karnataka Rheumatologists	9
Identification of ferroptosis-related molecular markers in glomeruli and tubulointerstitium of lupus nephritis	9
Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus	8
Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review	8
Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus	8
Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients	8
The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: A retrospective single-center study	8
Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity	8
Discovering the signature of a lupus-related microRNA profile in the Gene Expression Omnibus repository	8
A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients	8
Proton magnetic resonance spectroscopy (1H-MRS) in rheumatic autoimmune diseases: A systematic review	8
Low C4 as a risk factor for severe neuropsychiatric flare in patients with systemic lupus erythematosus	8
Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis	8
Association of MALAT-1 gene single nucleotide polymorphisms with genetic susceptibility to systemic lupus erythematosus	8
The combined role of clinical, reflectance confocal microscopy and dermoscopy applied to chronic discoid cutaneous lupus and subacutus lupus erythematosus: A case series and literature review	8
Cut off point of neutrophil-to-lymphocyte ratio as a marker of active disease in systemic lupus erythematosus	8
Prevalence of subclinical synovitis of the hand in patients with systemic lupus erythematosus	8
Dual trajectories of fatigue and disease activity in an inception cohort of adults with systemic lupus erythematosus over 10 years	8
IFNβ signaling inhibits osteogenesis in human SLE bone marrow	8
Cytokines, 25-OH vit D and disease activity in patients with juvenile-onset systemic lupus erythematosus	8
The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus	8
Pediatric systemic lupus erythematosus with lupus anticoagulant hypoprothrombinemia syndrome—A case series with review of literature	8
Role of micro-RNA132 and its long non coding SOX2 in diagnosis of lupus nephritis	8
Seroconversion to antinuclear antibody negativity and its association with disease flare in patients with systemic lupus erythematosus	8
Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study	8
Something new about prognostic factors for lupus nephritis? A systematic review	8
Unsupervised clustering analysis of data from an online community to identify lupus patient profiles with regards to treatment preferences	8
Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial	7
Associations between daily alcohol consumption and systemic lupus erythematosus-related cytokines and chemokines among US female nurses without SLE	7
Twenty-year trends in all-cause mortality of patients with systemic lupus erythematosus in Mexico: Results from a nationwide health registry	7
Systemic lupus erythematosus and COVID-19 during pregnancy	7
Role of interleukin-6 and interferon-α in systemic lupus erythematosus: A case–control study and meta-analysis	7
Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study	7

Associations of four common VDR polymorphisms with rheumatoid arthritis and systemic lupus erythematosus: evidence from a meta-analysis	7
Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab	7
Altered oxidative stress markers in relation to T cells, NK cells & killer immunoglobulin receptors that are associated with disease activity in SLE patients	7
Laboratory-confirmed pediatric COVID-19 in patients with rheumatic diseases: A case series in a tertiary hospital	7
Immunoglobulin levels in systemic lupus erythematosus: A narrative review	7
Venous thrombosis in a systemic lupus erythematosus patient with antiphospholipid antibodies coinciding with mild Covid-19	7
Incidence and prevalence of systemic lupus erythematosus among Korean women in childbearing years: A nationwide population-based study	7
Altered redox regulation by Nrf2-Keap1 system in dendritic cells of systemic lupus erythematosus patients	7
Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus	7
The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family	7
Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model	7
Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus	7
An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States	7
Autoimmune thyroid diseases, autoimmune hepatitis, celiac disease and type 1 diabetes mellitus in pediatric systemic lupus erythematosus: Results from the CARRA Legacy Registry	7
Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis	7
Low health numeracy is associated with higher disease activity in systemic lupus erythematosus	7
Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis	7
Nuclear magnetic resonance–based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis	7
Lupus aortitis: A fatal, inflammatory cardiovascular complication in systemic lupus erythematosus	7
Clinical characteristics of itch in cutaneous lupus erythematosus: A prospective, multicenter, multinational, cross-sectional study	7
Lupus nephritis: correlation of immunohistochemical expression of C4d, CD163-positive M2c-like macrophages and Foxp3-expressing regulatory T cells with disease activity and chronicity	7
Clinical characterization, outcomes, and prognosis in patients with systemic lupus erythematosus admitted to the intensive care unit	7
Comprehensive bioinformatics analysis of mRNA expression profiles and identification of a miRNA–mRNA network associated with lupus nephritis	7
Detection of putative autoantibodies in systemic lupus erythematous using a novel native-conformation protein microarray platform	7
Social media as source of information for Spanish-speaking patients with systemic lupus erythematosus	7
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab	7
Effect of early eradication therapy on systemic lupus erythematosus risk in patients with Helicobacter pylori infection: a nationwide population-based cohort study	7
Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy	7
MOG-IgG-associated disorder and systemic lupus erythematosus disease: Systematic review	6
Aggravation of discoid lupus erythematosus in a patient with psoriasis and psoriatic arthritis during treatment of secukinumab: A case report and review of literature	6
Applying SLICC and ACR/EULAR systemic lupus erythematosus classification criteria in a cohort of patients with undifferentiated connective tissue disease	6
Bullous lupus as the first manifestation of systemic lupus erythematosus in the pediatric population: A diagnostic challenge in daily practice	6
Nailfold capillaroscopy findings in cutaneous lupus erythematosus patients with or without digital lesions and comparison with dermatomyositis patients: A prospective study	6
Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life	6
Association between periodontitis and systemic lupus erythematosus: a meta-analysis	6
Differences in quality of life in patients with cutaneous lupus erythematosus with varying income levels	6
Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis	6
Hospitalization in patients with systemic lupus erythematosus at Tawam Hospital, United Arab Emirates (UAE): Rates, causes, and factors associated with length of stay	6
Identifying additional risk factors for arterial and venous thrombosis among pediatric antiphospholipid antibodies carriers	6
Sandplay therapy could be a method to decrease disease activity and psychological stress in children with systemic lupus erythematosus	6
Plasma immunoglobulin binding protein 1 as a predictor of development of lupus nephritis	6
Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis	6
Safety of tacrolimus use during pregnancy and related pregnancy outcomes in patients with systemic lupus erythematosus: A retrospective single-center analysis in Japan	6
Cotrimoxazole prophylaxis prevents major infective episodes in patients with systemic lupus erythematosus on immunosuppressants: A non-concurrent cohort study	6
Brain network reorganisation and spatial lesion distribution in systemic lupus erythematosus	6
Age differences in secular trends in black–white disparities in mortality from systemic lupus erythematosus among women in the United States from 1988 to 2017	6
Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients	6
Multimorbidity among incident Finnish systemic lupus erythematosus patients during 2000–2017	6
Mental health in patients with rheumatic diseases related to COVID-19 pandemic: Experience in a tertiary care center in Latin America	6
Prednisone and long-term damage in systemic lupus erythematosus: Which is the threshold dose? A pilot study	6
White matter microstructure alterations in systemic lupus erythematosus: A preliminary coordinate-based meta-analysis of diffusion tensor imaging studies	6
CD40 and CD72 expression and prognostic values among children with systemic lupus erythematosus: a case–control study	6
Diaphragmatic muscle thickness and diaphragmatic function are reduced in patients with systemic lupus erythematosus compared to those with primary Sjögren’s syndrome	6
Correlation between irreversible organ damage and the quality of life of patients with systemic lupus erythematosus: The Kyoto Lupus Cohort survey	6
Ambulatory blood pressure in patients with systemic lupus erythematosus: Association with markers of immune activation	6
Health care practitioners’ confidence assessing lupus-related rashes in patients of color	6
Systemic lupus erythematosus in children and adults: A retrospective study in Brazilian patients	6
Occurrence, predictors and outcome of infections at three months in hospitalized patients with SLE: A prospective study from Southern India	6
Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort	6
Association of microRNA-125a with the clinical features, disease activity and inflammatory cytokines of juvenile-onset lupus patients	6
Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE	6
Prevalence and incidence of systemic lupus erythematosus in Tucumán, Argentina	6
Association of MBL-2 gene polymorphisms with systemic lupus erythematosus: an updated meta-analysis and trial sequential analysis	6
CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study	6
Effects of web-based education and counselling for patients with systemic lupus erythematosus: self-efficacy, fatigue and assessment of care	6
Systemic lupus erythematosus and risk of sexual dysfunction: A systematic review and Meta-Analysis	6
The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations	6
Lower socioeconomic status worsens outcome of patients with systemic lupus erythematosus independently of access to healthcare	6
Vitamin D in Colombian patients with systemic lupus erythematosus and its correlation with disease activity	6
Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban	6
Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer	5
Systemic lupus erythematosus children in Egypt: Homeland spectrum amid the global situation	5
Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus	5
Validation and verification of the Japanese version of the systemic lupus erythematosus symptom checklist for patient quality of life	5
A prospective study of reproductive factors in relation to risk of systemic lupus erythematosus among black women	5
Identification and analysis of the predictive urinary exosomal miR-195-5p in lupus nephritis based on renal miRNA-mRNA co-expression network	5
Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study	5
The effect of smoking on cumulative damage in systemic lupus erythematosus: An incident cohort study	5
Metabolic syndrome predicts new damage in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort	5
Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina	5
Plant-based dietary changes may improve symptoms in patients with systemic lupus erythematosus	5
Health-related quality of life, fatigue and health utilities in lupus nephritis: A systematic literature review	5
Induced abortions in women with systemic lupus erythematosus	5
2019 ACR/EULAR classification criteria and therapy in predicting organ damage accrual in patients with childhood-onset systemic lupus erythematosus: A retrospective study over the last 29 years	5
Elevated apoptosis and abnormal apoptosis signaling of regulatory T cells in patients with systemic lupus erythematosus	5
Anti-recoverin antibodies indicate fundus abnormalities in systemic lupus erythematosus	5
Belimumab in subacute cutaneous lupus erythematosus	5
The changes in bone turnover markers of female systemic lupus erythematousus patients without glucocorticoid	5
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort	5
Intrarenal injection of mesenchymal stem cell for treatment of lupus nephritis in mice – a pilot study	5
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications	5
Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort	5
Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review	5
Association between alcohol intake and the risk of systemic lupus erythematosus: A systematic review and meta-analysis	5
Antiphospholipid antibodies and idiopathic infertility	5